ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
21.39
+0.12 (0.56%)
At close: Oct 22, 2025, 4:00 PM EDT
21.63
+0.24 (1.12%)
After-hours: Oct 22, 2025, 6:42 PM EDT
ACADIA Pharmaceuticals Market Cap
ACADIA Pharmaceuticals has a market cap or net worth of $3.61 billion as of October 22, 2025. Its market cap has increased by 47.69% in one year.
Market Cap
3.61B
Enterprise Value
2.90B
1-Year Change
47.69%
Ranking
Category
Stock Price
$21.39
Market Cap Chart
Since May 27, 2004, ACADIA Pharmaceuticals's market cap has increased from $112.80M to $3.61B, an increase of 3,099.25%. That is a compound annual growth rate of 17.56%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 22, 2025 | 3.61B | 18.19% |
Dec 31, 2024 | 3.05B | -40.60% |
Dec 29, 2023 | 5.14B | 99.41% |
Dec 30, 2022 | 2.58B | -31.29% |
Dec 31, 2021 | 3.75B | -55.85% |
Dec 31, 2020 | 8.50B | 28.98% |
Dec 31, 2019 | 6.59B | 225.79% |
Dec 31, 2018 | 2.02B | -45.92% |
Dec 29, 2017 | 3.74B | 7.07% |
Dec 30, 2016 | 3.49B | -2.91% |
Dec 31, 2015 | 3.60B | 13.57% |
Dec 31, 2014 | 3.17B | 39.50% |
Dec 31, 2013 | 2.27B | 762.44% |
Dec 31, 2012 | 263.30M | 361.93% |
Dec 30, 2011 | 57.00M | 20.76% |
Dec 31, 2010 | 47.20M | -6.53% |
Dec 31, 2009 | 50.50M | 51.20% |
Dec 31, 2008 | 33.40M | -91.84% |
Dec 31, 2007 | 409.20M | 56.24% |
Dec 29, 2006 | 261.90M | 13.18% |
Dec 30, 2005 | 231.40M | 102.63% |
Dec 31, 2004 | 114.20M | 1.24% |
May 27, 2004 | 112.80M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 729.35B |
Johnson & Johnson | 464.66B |
AbbVie | 403.98B |
UnitedHealth Group | 327.39B |
AstraZeneca | 259.95B |
Novartis AG | 255.24B |
Novo Nordisk | 237.27B |
Abbott Laboratories | 222.69B |